Polymedication among elderly: family physicians’ perception (research project)

Bibliographic Details
Main Author: Martins, Bárbara
Publication Date: 2023
Other Authors: Mendes, Ângela, Luis, Joana Gonçalves, Araújo, Rosa Maria
Format: Article
Language: por
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://doi.org/10.32385/rpmgf.v39i5.13518
Summary: Introduction: Polymedication is defined by the simultaneous use, appropriate or not, according to the comorbidities of each patient, of at least five drugs in the same person. The family physician (FP) should identify and combat, when clinically appropriate, polypharmacy. Objectives: To identify the prevalence of polymedication and the main potentially inappropriate pharmacological classes used in the elderly patients of the participating Family Health Unit and to evaluate the perception of FP about this reality. Methods: Analytical cross-sectional observational study in the population of patients aged 80 years or older. Patients without clinical records in the last three years were excluded. A questionnaire was distributed to FP to assess their perception of polymedication in their file. Data on the medication used by patients were obtained from SClinico® and PEM® software and analyzed in Excel®. Results: 386 patients were included, with a mean age of 85.6 years, 62% female. 79.5% of the patients were polymedicated, with an average of 7.1±3.1 drugs per patient. Statins corresponded to the most prescribed pharmacological group (64.2%), with benzodiazepines and proton pump inhibitors (PPIs) being the most commonly used potentially inappropriate classes in equal proportion (35%). Five FPs agreed to participate in the study; three correctly defined polymedication and showed an approximate perception of the reality of their file. The percentage of benzodiazepine use was overestimated by four clinicians; the prescription of anticoagulants was underestimated by three professionals, contrary to the use of antiaggregants and sulfonyloreas, which were overestimated in equal proportion. Discussion/Conclusion: This study allowed us to characterize the problem of polymedication in the unit investigated, enhancing individual and team awareness about this problem. Polymedication prevalence was higher than that reported in other studies. The researchers conclude that it is imperative to develop strategies to combat polymedication.
id RCAP_c773d1c920d40ece00d6620b4b854adc
oai_identifier_str oai:ojs.rpmgf.pt:article/13518
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Polymedication among elderly: family physicians’ perception (research project)Polimedicação no idoso: perceção dos médicos de família (projeto de investigação)IdosoPolimedicaçãoClasses de fármacos potencialmente inapropriadasElderlyPolymedicationPotentially inappropriate drug classesIntroduction: Polymedication is defined by the simultaneous use, appropriate or not, according to the comorbidities of each patient, of at least five drugs in the same person. The family physician (FP) should identify and combat, when clinically appropriate, polypharmacy. Objectives: To identify the prevalence of polymedication and the main potentially inappropriate pharmacological classes used in the elderly patients of the participating Family Health Unit and to evaluate the perception of FP about this reality. Methods: Analytical cross-sectional observational study in the population of patients aged 80 years or older. Patients without clinical records in the last three years were excluded. A questionnaire was distributed to FP to assess their perception of polymedication in their file. Data on the medication used by patients were obtained from SClinico® and PEM® software and analyzed in Excel®. Results: 386 patients were included, with a mean age of 85.6 years, 62% female. 79.5% of the patients were polymedicated, with an average of 7.1±3.1 drugs per patient. Statins corresponded to the most prescribed pharmacological group (64.2%), with benzodiazepines and proton pump inhibitors (PPIs) being the most commonly used potentially inappropriate classes in equal proportion (35%). Five FPs agreed to participate in the study; three correctly defined polymedication and showed an approximate perception of the reality of their file. The percentage of benzodiazepine use was overestimated by four clinicians; the prescription of anticoagulants was underestimated by three professionals, contrary to the use of antiaggregants and sulfonyloreas, which were overestimated in equal proportion. Discussion/Conclusion: This study allowed us to characterize the problem of polymedication in the unit investigated, enhancing individual and team awareness about this problem. Polymedication prevalence was higher than that reported in other studies. The researchers conclude that it is imperative to develop strategies to combat polymedication.Introdução: A polimedicação define-se pela utilização simultânea, apropriada ou não, de acordo com as comorbilidades de cada doente, de pelo menos cinco fármacos no mesmo utente.  O médico de família (MF) deve identificar e combater, quando clinicamente apropriado, a polifarmácia. Objetivos: Identificar a prevalência de polimedicação e as principais classes farmacológicas potencialmente inapropriadas utilizadas nos utentes muito idosos inscritos na Unidade de Saúde Familiar participante e avaliar a perceção dos MF sobre esta realidade. Método: Estudo observacional transversal analítico na população dos inscritos com idade igual ou superior a 80 anos. Foram excluídos os utentes sem registos clínicos nos últimos três anos. Distribuiu-se um questionário aos MF para avaliar a sua perceção face à polimedicação no seu ficheiro. Os dados relativos à medicação utilizada pelos utentes foram obtidos dos programas SClínico® e PEM® e analisados no Excel®. Resultados: Incluíram-se 386 utentes com idade média de 85,6 anos, 62% do sexo feminino. 79,5% dos utentes estavam polimedicados, com uma média de 7,1±3,1 fármacos por utente. As estatinas corresponderam ao grupo farmacológico mais prescrito (64,2%) dos pesquisados, com as benzodiazepinas e os inibidores da bomba de protões a constituírem as classes potencialmente inapropriadas mais utilizadas em igual proporção (35%). Cinco MF aceitaram participar no estudo; três definiram corretamente polimedicação e evidenciaram perceção aproximada da realidade na respetiva lista de utentes. A percentagem de utilização de benzodiazepinas foi sobrestimada por quatro clínicos; a prescrição de anticoagulantes foi subestimada por três profissionais, contrariamente à utilização de antiagregantes e sulfuniloreias, sobrestimados em igual proporção. Discussão/Conclusão: Este estudo permitiu caracterizar o problema da polimedicação na unidade investigada, potenciando a consciencialização individual e da equipa para esta problemática, sendo que a prevalência se revelou superior à relatada noutros estudos. As investigadoras concluem que é imperativo desenvolver estratégias de combate à polimedicação.Associação Portuguesa de Medicina Geral e Familiar2023-11-02info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.32385/rpmgf.v39i5.13518https://doi.org/10.32385/rpmgf.v39i5.13518Portuguese Journal of Family Medicine and General Practice; Vol. 39 No. 5 (2023): Revista Portuguesa de Medicina Geral e Familiar; 387-92Revista Portuguesa de Medicina Geral e Familiar; Vol. 39 Núm. 5 (2023): Revista Portuguesa de Medicina Geral e Familiar; 387-92Revista Portuguesa de Medicina Geral e Familiar; Vol. 39 N.º 5 (2023): Revista Portuguesa de Medicina Geral e Familiar; 387-922182-51812182-517310.32385/rpmgf.v39i5reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPporhttps://rpmgf.pt/ojs/index.php/rpmgf/article/view/13518https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13518/11889Direitos de Autor (c) 2023 Revista Portuguesa de Medicina Geral e Familiarinfo:eu-repo/semantics/openAccessMartins, BárbaraMendes, ÂngelaLuis, Joana GonçalvesAraújo, Rosa Maria2024-09-17T12:00:35Zoai:ojs.rpmgf.pt:article/13518Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T18:52:51.413318Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Polymedication among elderly: family physicians’ perception (research project)
Polimedicação no idoso: perceção dos médicos de família (projeto de investigação)
title Polymedication among elderly: family physicians’ perception (research project)
spellingShingle Polymedication among elderly: family physicians’ perception (research project)
Martins, Bárbara
Idoso
Polimedicação
Classes de fármacos potencialmente inapropriadas
Elderly
Polymedication
Potentially inappropriate drug classes
title_short Polymedication among elderly: family physicians’ perception (research project)
title_full Polymedication among elderly: family physicians’ perception (research project)
title_fullStr Polymedication among elderly: family physicians’ perception (research project)
title_full_unstemmed Polymedication among elderly: family physicians’ perception (research project)
title_sort Polymedication among elderly: family physicians’ perception (research project)
author Martins, Bárbara
author_facet Martins, Bárbara
Mendes, Ângela
Luis, Joana Gonçalves
Araújo, Rosa Maria
author_role author
author2 Mendes, Ângela
Luis, Joana Gonçalves
Araújo, Rosa Maria
author2_role author
author
author
dc.contributor.author.fl_str_mv Martins, Bárbara
Mendes, Ângela
Luis, Joana Gonçalves
Araújo, Rosa Maria
dc.subject.por.fl_str_mv Idoso
Polimedicação
Classes de fármacos potencialmente inapropriadas
Elderly
Polymedication
Potentially inappropriate drug classes
topic Idoso
Polimedicação
Classes de fármacos potencialmente inapropriadas
Elderly
Polymedication
Potentially inappropriate drug classes
description Introduction: Polymedication is defined by the simultaneous use, appropriate or not, according to the comorbidities of each patient, of at least five drugs in the same person. The family physician (FP) should identify and combat, when clinically appropriate, polypharmacy. Objectives: To identify the prevalence of polymedication and the main potentially inappropriate pharmacological classes used in the elderly patients of the participating Family Health Unit and to evaluate the perception of FP about this reality. Methods: Analytical cross-sectional observational study in the population of patients aged 80 years or older. Patients without clinical records in the last three years were excluded. A questionnaire was distributed to FP to assess their perception of polymedication in their file. Data on the medication used by patients were obtained from SClinico® and PEM® software and analyzed in Excel®. Results: 386 patients were included, with a mean age of 85.6 years, 62% female. 79.5% of the patients were polymedicated, with an average of 7.1±3.1 drugs per patient. Statins corresponded to the most prescribed pharmacological group (64.2%), with benzodiazepines and proton pump inhibitors (PPIs) being the most commonly used potentially inappropriate classes in equal proportion (35%). Five FPs agreed to participate in the study; three correctly defined polymedication and showed an approximate perception of the reality of their file. The percentage of benzodiazepine use was overestimated by four clinicians; the prescription of anticoagulants was underestimated by three professionals, contrary to the use of antiaggregants and sulfonyloreas, which were overestimated in equal proportion. Discussion/Conclusion: This study allowed us to characterize the problem of polymedication in the unit investigated, enhancing individual and team awareness about this problem. Polymedication prevalence was higher than that reported in other studies. The researchers conclude that it is imperative to develop strategies to combat polymedication.
publishDate 2023
dc.date.none.fl_str_mv 2023-11-02
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.32385/rpmgf.v39i5.13518
https://doi.org/10.32385/rpmgf.v39i5.13518
url https://doi.org/10.32385/rpmgf.v39i5.13518
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13518
https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13518/11889
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2023 Revista Portuguesa de Medicina Geral e Familiar
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2023 Revista Portuguesa de Medicina Geral e Familiar
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Associação Portuguesa de Medicina Geral e Familiar
publisher.none.fl_str_mv Associação Portuguesa de Medicina Geral e Familiar
dc.source.none.fl_str_mv Portuguese Journal of Family Medicine and General Practice; Vol. 39 No. 5 (2023): Revista Portuguesa de Medicina Geral e Familiar; 387-92
Revista Portuguesa de Medicina Geral e Familiar; Vol. 39 Núm. 5 (2023): Revista Portuguesa de Medicina Geral e Familiar; 387-92
Revista Portuguesa de Medicina Geral e Familiar; Vol. 39 N.º 5 (2023): Revista Portuguesa de Medicina Geral e Familiar; 387-92
2182-5181
2182-5173
10.32385/rpmgf.v39i5
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833597726250500096